IP16: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Overactive Bladder
Friday, May 15, 2026 1:00 PM to 3:00 PM · 2 hr. (America/New_York)
146C
Poster and Podium Sessions
Voiding Dysfunction
Friday, May 15
IP16-01: COMPARING URINARY URGENCY PATIENTS WITH AND WITHOUT PAIN — A LURN II STUDY
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Henry Lai · University of Iowa
IP16-02: COMPARING SYMPTOM PRESENTATION, TREATMENT PATTERNS, AND SYMPTOM TRAJECTORIES BETWEEN MEN AND WOMEN WITH URINARY URGENCY — A LURN II STUDY
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Henry Lai · University of Iowa
IP16-03: A prospective longitudinal study of urinary metabolites among women with and without overactive bladder
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Ashley Harrie · University of Michigan Medical School
IP16-04: Proteomic Analysis of Human Urothelium Reveals Distinct Molecular Mechanisms Underlying Overactive Bladder due to Bladder Outlet Obstruction
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Gun-Hwa Kim · Korea Basic Science Institute
IP16-05: URINE IN INDIVIDUALS WITH OVERACTIVE BLADDER HARBORS GREATER ABUNDANCE OF CALCIUM- AND FAD-BINDING PEPTIDES RELATIVE TO HEALTHY CONTROLS
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Glenn Werneburg · University of Michigan
IP16-06: Serum Uric Acid Partially Mediates Nocturia-Associated Mortality: NHANES Analysis
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Sung Tae Cho · Hallym University Kangnam Sacred Heart Hospital
IP16-07: Skin Sympathetic Nerve Activity Reflects Sympathetic Overactivation in a Rat Model of Overactive Bladder Induced by Partial Bladder Outlet Obstruction
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Yu-Chen Chen · Kaohsiung Medical University Hospital
IP16-08: Regional White Matter Differences in Overactive Bladder Identified by Diffusion Tensor Imaging: Five Distinct Clusters Including Two Accessible to Brain Optical Technologies
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Lynn Stothers · UCLA
IP16-09: A NON-INVASIVE APPROACH TO DETECTNG DETRUSOR OVERACTIVITY IN PATIENTS WITH OVERACTIVE BLADDER VIA BLADDER NEAR-INFRARED SPECTROSCOPY
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Vandanaa Jayaprakash · Virginia Commonwealth University School of Medicine
IP16-10: ALTERATIONS IN BLADDER HEMODYNAMICS USING NEAR-INFRARED SPECTROSCOPY IN FEMALES WITH OVERACTIVE BLADDER AND NORMAL HEALTHY CONTROLS
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Joseph Schultz
IP16-11: PEOPLE WITH URGENCY HAVE DIFFERENT SENSATIONS TO URINATE: A LURN II STUDY
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Joanna Marantidis · University of Michigan
IP16-12: IS THERE A CENTRAL SENSITIZATION PHENOTYPE IN FEMALES WITH OVERACTIVE BLADDER?
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
William Furuyama · Vanderbilt University
IP16-13: Hidden Voiding Dysfunction in Refractory Female Overactive Bladder: Insights from Real-World Urodynamic Profiling
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Yoshihisa Matsukawa
IP16-14: Urodynamic correlates of anticholinergic burden: evidence for cholinergic saturation and detrusor overactivity supression
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Jo�o Pedro Oliveira · Faculdade de Medicina da Universidade do Porto
IP16-15: A COMPARISON OF UROGYNECOLOGY AND RECONSTRUCTIVE PELVIC SURGERY (URPS) VS NON-URPS-INTERPRETED URODYNAMIC STUDIES (UDS): DIFFERENCES IN COMPLETENESS AND OUTCOMES
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Mashtura Hasan
IP16-16: What Level of Benefit Justifies Beta-3 Agonist Therapy for Overactive Bladder? Estimating the Patient-Perceived Treatment Threshold Using the Smallest Worthwhile Difference Approach
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Kenji Omae
IP16-18: Beyond Glycemic Control: Concurrent GLP-1 Receptor Agonist Use Is Associated with Reduced Urinary Adverse Events Following OnabotulinumtoxinA Treatment in Non-Diabetic Adults with Overactive Bladder
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Sophia Quesada
IP16-19: Intradetrusor OnabotulinumtoxinA is Safe and Effective in Men with Overactive Bladder following Stress Urinary Incontinence Surgery
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Randy Tsai · David Geffen School of Medicine at UCLA
IP16-20: Initiation of de-novo medical therapy for overactive bladder after bladder outlet procedures
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Michael Uy · University of Michigan
IP16-21: Incidence of and Time to Minimally Invasive Therapy among Patients with Idiopathic Overactive Bladder
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Andria Li · Vanderbilt
IP16-22: Comparative outcomes for minimally invasive therapies for idiopathic overactive bladder in older adults: A national study of Medicare beneficiaries
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Unwanaobong Nseyo · Weill Cornell Medicine
IP16-23: Real-world experience with implantable tibial nerve stimulation in patients with and without prior failed neuromodulation for overactive bladder
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Francis Jefferson · University of Texas Southwestern Medical Center
IP16-24: Exploring patient perspectives on sacral neuromodulation: a qualitative analysis of online discussions
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Maria D'Amico · Cleveland Clinic Foundation
IP16-25: Occupational Voiding Restrictions Associated with Overactive Bladder Symptoms: Low Income Individuals Most Affected
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Arshia Aalami Harandi
IP16-26: Understanding Primary Care Provider Urinary Incontinence Knowledge
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Sweta Parija · University of California, San Diego
IP16-27: Post-Micturition Dribbling: New Insights into the Role of Post-Void Residual Volume and After-Contractions — A Prospective Study
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
YEHONATAN YACOBI
IP16-28: COMPARATIVE ASSESSMENT OF TWO STANDARD OF CARE PAIN MANAGEMENT PROTOCOLS FOR INTRADETRUSOR ONABOTULINUMTOXINA INJECTIONS IN A DIVERSE URBAN PATIENT POPULATION
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Grace Khaner · Albert Einstein College of Medicine
IP16-29: Intradetrusor OnabotulinumtoxinA is Safe and Effective in Men with Overactive Bladder following Radical Prostatectomy or Outlet Surgery
Friday, May 15, 2026 1:00 PM to 3:00 PM
146C
Randy Tsai · David Geffen School of Medicine at UCLA
